Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Photocure establishes Named Patient Program to provide access to Hexvix in South…
"Without this NPP, BLC with Hexvix would not otherwise be available to bladder cancer patients in South Africa. Photocure is committed to ensuring global access to Hexvix as part of its sustainability goals," said Dan Schneider, President and CEO of Photocure. "We see this program as a stepstone to trialing various ways in which Hexvix can be made available to patients and urologists in countries where BLC equipment is already accessible." "Without this NPP, BLC with…
PR Newswire
27/09/2024
Casino Group: Real estate asset sales
Casino Group sells over €200m of commercial real estate assets to Tikehau Capital Paris, 27 September 2024Following the signature in June 2024 of an agreement with Tikehau Capital covering a portfolio of 30 real estate assets, Casino Group announced that on Thursday, 26 September 2024 it had finalized the sale of 26 of these, for a net selling price of over 200 million euros, excluding subsequentearn-outs. The sale of the remaining assets, provided for in the agreements, will be...
Nasdaq GlobeNewswire
27/09/2024
Information on the total number of voting rights and shares
REGULATED INFORMATIONInformation on the total number of voting rights and sharesMont-Saint-Guibert(Belgium), September 27, 2024 , 08:05 am CET / 2:05 am ET –In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 5,907,711.21 Total number of securities carrying voting rights: 34,389,015 (all ordinary...
Nasdaq GlobeNewswire
27/09/2024
Publication relating to transparency notifications
REGULATED INFORMATIONPublication relating to transparency notificationsMont-Saint-Guibert(Belgium), September 27, 2024 , 8.00am CET / 2.00am ET –In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.BlackRock, Inc.On September 24, 2024, Nyxoah received a transparency notification from...
Nasdaq GlobeNewswire
27/09/2024
Medit Expands Intraoral Scanner Presence in Slovenia and the Balkans
Visitors to Medit's booth will explore how these scanners can enhance diagnostic accuracy and operational efficiency in modern dental practices. They will also have the opportunity to engage with Medit's experts and discover how its technology supports clinicians and technicians in delivering high-quality dental services. Visitors to Medit's booth will explore how these scanners can enhance diagnostic accuracy and operational efficiency in modern dental practices. They will also have the...
PR Newswire
27/09/2024
EADV Congress 2024: New research confirms link between perceived stress and…
In the study, psoriatic lesions were induced in healthy human skin xenografts on mice (n=25) through the injection of autologous, in vitro IL-2-preactivated peripheral blood mononuclear cells. After achieving lesion remission with topical dexamethasone, the mice were exposed to either sonic (sound) or sham stress for 24 hours. The recurrence of psoriatic lesions was then tracked over the following 14 days. In the study, psoriatic lesions were induced in healthy human skin xenografts on mice...
PR Newswire
27/09/2024
Global Hormone Replacement Therapy Market to Grow Substantially at a CAGR of ~6%…
Key Takeaways from the Hormone Replacement Therapy Market Report Key Takeaways from the Hormone Replacement Therapy Market Report To read more about the latest highlights related to the hormone replacement therapy market, get a snapshot of the key highlights entailed in theGlobal Hormone Replacement Therapy Market Report Hormone Replacement Therapy Overview Hormone replacement therapy (HRT) is a medical treatment commonly used to alleviate symptoms associated with menopause,...
PR Newswire
26/09/2024
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company Announcement COPENHAGEN, Denmark; September 26, 2024 –Genmab A/S(Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the...
Nasdaq GlobeNewswire
26/09/2024
AI in Life Sciences Market Poised for Explosive Growth with 27.9% CAGR Through…
The global artificial intelligence (AI) in the life sciences market is witnessing significant growth, driven by advancements in AI technologies and their increasing adoption across the life sciences sector. This report provides a comprehensive analysis of the market size, estimating both current and historical revenues segmented by products, applications, end users, and regions. By examining these factors, the report offers insights into the evolving landscape of AI in life sciences…
PR Newswire
26/09/2024
Global Theranostics Market to Triple, Reaching $12.7 Billion by 2029
The theranostics market is robust and dynamic, characterized by a diverse array of companies offering comprehensive solutions. Major players in the market, including leaders in diagnostics and therapeutics, are profiled extensively, detailing their revenues, product portfolios, and recent strategic initiatives. The competitive landscape is thoroughly examined alongside market trends and key dynamics such as drivers, restraints, and opportunities. Segmented by product type, theranostics offerings…
PR Newswire
26/09/2024
LiveWell Awarded Frost & Sullivan's 2024 Global Customer Value Leadership Award…
In their report, Frost & Sullivan state that LiveWell provides world-class digital health and well-being solutions to balance physical, mental, social, and financial health through its user-friendly app. LiveWell offers a wide range of tools that include mood and stress tracking; mental health support; and services offering support on a range of wellness topics. LiveWell is one of many pioneers addressing significant challenges to the mental and behavioral health industry, such as stigma…
PR Newswire
26/09/2024
Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib…
MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved engraftment and bone marrow reconstitution potential of patient derived hematopoietic stem cellsIn vitro data also demonstrated improved ability to differentiate to erythroid cells, supporting potential for improvement in biomarkers of anemiaHAIFA, Israel, Sept.26, 2024...
Nasdaq GlobeNewswire
26/09/2024
OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate…
OSE Immunotherapeutics Announces Historic H1 2024 Results andProvides Corporate Update Financial and business highlightsTotal H1 2024 incomes of €82.5 million thanks to Company's new partnerships.New strategic partnership with AbbVie for up to $713 million, including $48 million received upon signature.Major partnership expansion with Boehringer Ingelheim: Amendment of the collaboration and licensing agreement on first-in-class SIRPα compounds developed both in...
Nasdaq GlobeNewswire
26/09/2024
Vistin Pharma ASA: Mandatory notification of trade
Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure ASA is closely associated with board member Øystein Stray Spetalen. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment 20240926_Notification of trade_Saga i Vistin
Nasdaq GlobeNewswire
26/09/2024
Medical Gas and Equipment Market to Hit USD 26.44 Billion by 2029 with 5.8% CAGR…
Browse in-depth TOC on "Medical Gas and Equipment Market" Browse in-depth TOC on "Medical Gas and Equipment Market" 394 - Tables 60 - Figures 380 - Pages By type, the medical gas and equipment market is segmented into medical gases and medical gas equipment. In 2023, the medical gas segment accounted for the largest share in the medical gas and equipment market due to the essential role of gases in various medical applications, including anesthesia, respiratory therapy…
PR Newswire
26/09/2024
AbZelectPRO™ enables biopharma customers to reach their research cell bank in 10…
Simon Keen, VP of Cell Line Development at Abzena, states: "Our goal with AbZelectPRO™ was to offer our customers a strong cell line development platform with shorter timelines, higher production levels and lower production costs. When we launched the platform in January 2024, we were utilizing data from initial research and development projects. Over the past 10 months we've been fine-tuning the platform, generating more data from real-world projects, which has allowed us to showcase its…
PR Newswire
26/09/2024
Bavarian Nordic Upgrades its Financial Guidance for 2024
COPENHAGEN, Denmark, September 26, 2024– Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024.Based on today's announced mpox vaccine order and additional orders secured, combined with improved performance in Travel Health, as well as other parts of the business, Bavarian Nordic now expects revenue between DKK 5,400 million and DKK 5,800 million and EBITDA between DKK 1,450 million and DKK 1,700 million.Revenue from the Travel Health business is now expected at...
Nasdaq GlobeNewswire
26/09/2024
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
First award under UNICEF emergency tender to secure availability of mpox vaccines for AfricaCOPENHAGEN, Denmark, September 26, 2024– Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN ®mpox vaccine for countries in Africa impacted by the mpox outbreak.Under the agreement, UNICEF will procure 1 million doses of the vaccine which includes the 500,000 doses that were committed by Gavi and announced on September...
Nasdaq GlobeNewswire
26/09/2024
Cleanroom Technologies Market to Hit USD 12.3 Billion by 2029 with 6.9% CAGR |…
Browse in-depth TOC on "Cleanroom Technologies Market" Browse in-depth TOC on "Cleanroom Technologies Market" 350 - Tables 280 - Figures 400 - Pages Based on Type, the cleanroom technologies market has been segmented into standard cleanrooms, modular cleanrooms and mobile cleanrooms. The modular cleanroom is further segmented into hardwall cleanrooms and softwall cleanrooms. The modular cleanrooms segment accounted for the largest share of the cleanroom technologies market...
PR Newswire
26/09/2024
Urteste Expands Development of Innovative Diagnostic Projects
Urteste Expands Development of Innovative Diagnostic ProjectsGdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT), a biotechnology company specializing in the development of breakthrough technology to detect cancer from urine samples, best known for its flagship project PANURI, a diagnostic test for pancreatic cancer. The company's breakthrough technology allows for early detection of cancer by measuring the activity of enzymes present...
Nasdaq GlobeNewswire
26/09/2024
Infectious Disease Therapeutics Market Surges to USD 140.71 Billion by 2030…
Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=817164 Download PDF Brochure: https://www.verifiedmarketreports.com/download-sample/?rid=817164 Browse in-depth TOC onInfectious Disease Therapeutics Market 202 - Pages 126 – Tables 37 – Figures Scope of The Report Global Infectious Disease Therapeutics Market Overview Market Drivers Fueling Growth in the Infectious Disease Therapeutics Market Rising Prevalence of Infectious...
PR Newswire
26/09/2024
Coronado Research announce appointment of Gail Kniveton to Chief Talent Officer…
Kniveton commented, "I am delighted to be joining an organisation that places employee needs at the top of the agenda. I have always focussed my work on businesses with high innovation, looking to change working practices and finding "unicorn people" to lead them. Coronado Research aligns perfectly with my passion for creating high performing, high innovation teams. We already have a great team lined up and I look forward to bringing them into Coronado over the coming months and…
PR Newswire
26/09/2024
ZEISS reinvents lens extraction with the first hand-held ultrasound-free lens…
"We're putting the future of lens extraction in the hands of surgeons today," says Euan S. Thomson, Ph.D., President of Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. "The ZEISS MICOR 700 extends our cataract solutions portfolio and serves as a testament to ZEISS's ability to deliver revolutionary, state-of-the-art technologies that advance cataract surgery, benefiting both patients and surgeons." "We're putting…
PR Newswire
26/09/2024
Wyoming Medicaid Becomes First State to Cover Cognoa's Canvas Dx, Expanding…
In Wyoming, as in many states, autism remains under-detected. The average age of diagnosis is 6.1 years – over a year later than the U.S. average of 5 years, and more than 4.5 years after a reliable diagnosis is generally possible, at 18 months. Families in Wyoming travel up to 224 miles for an autism evaluation, creating additional barriers to timely diagnosis and intervention and underscoring the scarcity of services. InWyoming, as in many states, autism remains under-detected. The average...
PR Newswire
26/09/2024
Altri Comunicati